Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.78%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
8.43 Down 1.47(14.85%) 3:25PM EDT
Add to Portfolio
Prev Close:9.90
Open:9.21
Bid:8.42
Ask:8.82
1y Target Est:N/A
Beta:0.66
Earnings Date:May 6 - May 15 (Est.)
Day's Range:8.00 - 9.26
52wk Range:4.80 - 10.29
Volume:8,125
Avg Vol (3m):1,463
Market Cap:296.98M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-15) :-1.31
Quarterly EPS Est (Mar-15) :-0.16
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback